Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
Publication Number | Title | Priority Date |
---|---|---|
US-2020207758-A1 | 3-(1h-pyrazol-4-yl)pyridine allosteric modulators of the m4 muscarinic acetylcholine receptor | 2017-06-27 |
WO-2019000236-A1 | ALLOSTERIC MODULATORS OF 3- (1H-PYRAZOL-4-YL) PYRIDINE FROM THE M4 ACETYLCHOLINE MUSCARINIC RECEPTOR | 2017-06-27 |
US-11149036-B2 | 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor | 2017-06-27 |
EA-037563-B1 | NEW (HETERO) ARYL-SUBSTITUTED PIPERIDINYL DERIVATIVES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016-12-28 |
EP-3468971-B1 | New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | 2016-06-10 |
KR-102003532-B1 | Novel (hetero) aryl-substituted-piperidinyl derivatives, methods for their preparation and pharmaceutical compositions containing them | 2016-06-10 |
KR-20190017032-A | Novel (hetero) aryl-substituted-piperidinyl derivatives, methods for their preparation and pharmaceutical compositions containing them | 2016-06-10 |
US-10654849-B2 | (Hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | 2016-06-10 |
US-2019144449-A1 | (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | 2016-06-10 |